| The Israeli abortion committees' process of decision making: an ethical analysis. | |
| | |
MedLine Citation:
|
PMID: 21693566 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The Israeli law of abortions (1977) legally authorises hospital committees to decide upon women's requests for selective abortion. One of the law's clauses determines that abortions can be approved in cases of an embryopathy. However, the law does not provide any clear definitions of those fetal 'physical or mental defects' in terms of severity and/or likelihood, which remain open to interpretation by the committee members. This paper aimed to determine which ethical methodologies are used by committee members and advisors as they face the dilemma of abortion approval due to mild to moderate possible embryopathy. Twenty interviews demonstrated that they use mainly a combination of deontology and a contextual-relational model. Their ethical considerations are both contextual such as the family's/woman's relational network and are influenced by the ethical principles of autonomy and in cases of late abortions the value of life. The findings reveal a paradoxical picture: on the one hand, committee members hold liberal perceptions and in practice abortion requests are very seldom rejected. On the other hand, the Israeli abortion law and practice of abortion committees is still problematical from liberal and feminist rights perspectives. This paradox is discussed further by reflecting upon the relevant theory as well as the Israeli context. The paper concludes by suggesting that within the specific Israeli sociopolitical climate the requirement for committee approval of what should be a private decision might be necessary in order to placate religious or other opposition to abortion. |
| | |
Authors:
|
Nitzan Rimon-Zarfaty; Alan Jotkowitz |
Related Documents
:
|
22045856 - Pediatric use of complementary and alternative medicine: legal, ethical, and clinical i... 22373766 - Ethical issues of placebo-controlled studies in depression and a randomized withdrawal ... 8680266 - Clinical practice by certificate holders in the profession in which they are not certif... 10120986 - Ethics in health care, part ii: the product of shared deliberation. working within a pl... 19472256 - From single-biomolecule electrochemistry to biosensors and biofuel cells. 10727286 - New frontiers in gold labeling: symposium overview. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-21 |
Journal Detail:
|
Title: Journal of medical ethics Volume: - ISSN: 1473-4257 ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-22 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7513619 Medline TA: J Med Ethics Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Sociology and Anthropology, Ben-Gurion University of the Negev, Beer-Sheva, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: MMP-2 and MMP-9 in lymph-node-positive bladder cancer.
Next Document: Research and complicity: the case of Julius Hallervorden.